Telesis Bio, Inc.
Dry Powder Formulations for Messenger RNA
Last updated:
Abstract:
The present invention provides stable, dry powder messenger RNA formulations for therapeutic use, and methods of making and using the same.
Status:
Application
Type:
Utility
Filling date:
23 Jul 2019
Issue date:
9 Dec 2021